A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.

BOISE — A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk ...

The mum was diagnosed with the BRCA2, which heightened her risk of breast cancerCredit: SWNS Sharni had been found to have the BRCA2 gene in 2018, which can increase the risk of cancer if it's faulty.

Around 50 out of 100 women with either a BRCA1 or BRCA2 gene mutations will get breast cancer by the time they are 70, while only to only 7 out of 100 women without the gene will develop cancer in ...

A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk patients ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in the part of the gene that is central to BRCA2 function, according to ...

Followed categories will be added to My News. She has one of the most commonly inherited gene mutations – BRCA2 – which increases the risk of breast, ovarian and prostate cancers. Mia tested ...

MRC Holland recently announced that five SALSA MLPA assays for the detection of hereditary breast and ovarian cancer (HBOC) ...

"Around 40% of HGSOC has an inherited component and some of this is due to well-known genes like BRCA1 and BRCA2, for which testing is available," he said. "Our research set out to uncover new ...